Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Use of products containing genetic material (e.g., pDNA, antisense DNA, si RNA) to treat a disease or condition, or to modify or manipulate the expression of genetic material or to alter the biological properties of living cells.
Use of products containing genetic material (e.g., pDNA, antisense DNA, si RNA) to treat a disease or condition, or to modify or manipulate the expression of genetic material or to alter the biological properties of living cells.
Time required for the concentration of a reactant in a given reaction to reach a value that is the arith- metic mean of its initial and final (equilibrium) values.
Time required for the concentration of a reactant in a given reaction to reach a value that is the arith- metic mean of its initial and final (equilibrium) values.